Lara Console

Via Bucci 4C
Arcavacata, 87036, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Therapeutic potential of mitochonic acid (MA-5) in modulating mitochondrial function and inflammatory responses: A focus on carnitine/acylcarnitine carrier (SLC25A20) transport activity.

Therapeutic potential of mitochonic acid (MA-5) in modulating mitochondrial function and inflammatory responses: A focus on carnitine/acylcarnitine carrier (SLC25A20) transport activity.

Journal: Biochemical pharmacology

Published: April 23, 2026

Cholesterol, but not its oxidized derivatives, is essential for the transport activity of ASC1 (SLC7A10).

Cholesterol, but not its oxidized derivatives, is essential for the transport activity of ASC1 (SLC7A10).

Journal: Free radical biology & medicine

Published: January 27, 2026

Structure/function relationships of mitochondrial protein carrier (SLC25A20) for carnitine/acylcarnitine: A review.

Structure/function relationships of mitochondrial protein carrier (SLC25A20) for carnitine/acylcarnitine: A review.

Journal: Biochimica et biophysica acta. Biomembranes

Published: December 25, 2025

Characterization of the lysosomal arginine transporter SLC7A14.

Characterization of the lysosomal arginine transporter SLC7A14.

Journal: Scientific reports

Published: December 17, 2025

The APOL1 variant p.N264K is predicted to block ion flow by occluding a pore at the cell surface.

The APOL1 variant p.N264K is predicted to block ion flow by occluding a pore at the cell surface.

Journal: Life science alliance

Published: November 17, 2025

Crossing the Borders: the amino acid transporter LAT1 (SLC7A5) in the Blood-Brain Barrier.

Crossing the Borders: the amino acid transporter LAT1 (SLC7A5) in the Blood-Brain Barrier.

Journal: Neurochemistry international

Published: July 23, 2025

The antiport mechanism of the human LAT1 transporter: defining the molecular determinants by means of wet and dry approaches.

The antiport mechanism of the human LAT1 transporter: defining the molecular determinants by means of wet and dry approaches.

Journal: Biochemical and biophysical research communications

Published: June 22, 2025

Altered dimerization of certain riboflavin transporter 2 mutants: a possible source of UPR, altered calcium signalling and mitochondrial derangements in RTD2.

Altered dimerization of certain riboflavin transporter 2 mutants: a possible source of UPR, altered calcium signalling and mitochondrial derangements in RTD2.

Journal: Archives of biochemistry and biophysics

Published: May 16, 2025

Impact of 7-ketocholesterol on the function and stability of the LAT1 transporter.

Impact of 7-ketocholesterol on the function and stability of the LAT1 transporter.

Journal: Biochemical pharmacology

Published: February 24, 2025

Production of the recombinant human riboflavin transporters SLC52A1, 3 and functional assay in proteoliposomes.

Production of the recombinant human riboflavin transporters SLC52A1, 3 and functional assay in proteoliposomes.

Journal: Archives of biochemistry and biophysics

Published: December 10, 2024

Supplying LSD1 with FAD in pancreatic cancer: A matter of protein-protein interaction?

Supplying LSD1 with FAD in pancreatic cancer: A matter of protein-protein interaction?

Journal: Archives of biochemistry and biophysics

Published: November 25, 2024

OCTN1 (SLC22A4) as a Target of Heavy Metals: Its Possible Role in Microplastic Threats.

OCTN1 (SLC22A4) as a Target of Heavy Metals: Its Possible Role in Microplastic Threats.

Journal: International journal of molecular sciences

Published: October 30, 2024

Showing 1-12 of 70

Last Updated: 09/26/2026